# Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora

> **NCT00312338** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 137 (actual)

## Conditions studied

- Bacterial Conjunctivitis

## Interventions

- **DRUG:** VIGAMOX

## Key facts

- **NCT ID:** NCT00312338
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 137 (ACTUAL)
- **Last updated:** 2012-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00312338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00312338, "Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00312338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*